We strive to make that fear of the unknown as reduced as possible, and always encourage our clients to ask as many questions as they need
The arginate salt form of BPC-157 demonstrates dramatically different oral pharmacokinetics compared to the acetate form
When cortisol stays elevated, belly fat accumulates, sleep suffers, and mood worsens
Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone
taking doses too close together pushes concentrations into the 15-20 ng/mL range where severe GI effects occur
If thats important to you, Transparent Labs may be the better choice
